Alemtuzumab Induction Reduces Early Rejection in Female Renal Allograft Recipients: A Single Center Study.

CONCLUSIONS: Compared with men, early female rejection is reduced and overall female survival is longer after alemtuzumab induction. However, intermediate-term female graft survival is less.
PMID: 29633926 [PubMed - as supplied by publisher]

Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - April 9, 2018 Category: Transplant Surgery Authors: Demeter J, Buck B, Zimmerman A, Mitro G, Rees M, Ortiz J Tags: Exp Clin Transplant Source Type: research